Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 7/20 | 0.36 |
| ▸ | LMNA | P02545 | 6/20 | 0.36 |
| ▸ | MAPT | P10636 | 12/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.35 |
| ▸ | MEN1 | O00255 | 6/20 | 0.35 |
| ▸ | GAA | P10253 | 6/20 | 0.35 |
| ▸ | THRB | P10828 | 3/20 | 0.35 |
| ▸ | RECQL | P46063 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14866171 | 0.89 | KDM4E (0.41) | KDM4EL3MBTL1ATMPGR | |
| SCHEMBL22628125 | 0.88 | L3MBTL1 (0.41) | KDM4EL3MBTL1ATMHTTMAPT | |
| SCHEMBL24699496 | 0.85 | KDM4E (0.39) | KDM4EL3MBTL1ATMHTTLMNA | |
| SCHEMBL12282052 | 0.82 | KDM4E (0.45) | KDM4EL3MBTL1ATMHTTMAPT | |
| SCHEMBL20127227 | 0.81 | PGR (0.36) | KDM4EL3MBTL1ATMPGR | |
| SCHEMBL21578546 | 0.79 | KDM4E (0.33) | KDM4EL3MBTL1ATM | |
| SCHEMBL23919957 | 0.79 | KDM4E (0.33) | KDM4EL3MBTL1ATM | |
| SCHEMBL23919613 | 0.78 | KDM4E (0.32) | KDM4EL3MBTL1ATM | |
| SCHEMBL23919698 | 0.78 | KDM4E (0.35) | KDM4EL3MBTL1ATM | |
| SCHEMBL21973984 | 0.77 | L3MBTL1 (0.46) | KDM4EL3MBTL1ATMHTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11758809-B2 | Compound, display panel, and display apparatus | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2023-09-12 | — | — | US | disclosed |
| US-11667618-B2 | Azulene ring-containing compound, its use, and an organic photoelectric device including the same | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-06-06 | — | — | US | disclosed |
| WO-2021036978-A1 | TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF | CHE CHI MING (CN) | 2021-03-04 | — | — | WO | disclosed |
| US-20200140416-A1 | COMPOUND, OLED DISPLAY PANEL AND ELECTRONIC DEVICE | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667618-B2 | Azulene ring-containing compound, its use, and an organic photoelectric device including the same | CCNE2, CCNE1, ESR1 | KDM4E 1014/4885L3MBTL1 3755/4885ATM 831/4885 |
| US-20200140416-A1 | COMPOUND, OLED DISPLAY PANEL AND ELECTRONIC DEVICE | OCIAD2, OCIAD1, EED | KDM4E 2113/4885L3MBTL1 2864/4885ATM 3949/4885 |
| US-11758809-B2 | Compound, display panel, and display apparatus | C1S, C3AR1, DRD3 | KDM4E 4098/4885L3MBTL1 3173/4885ATM 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.